Skip to main content

Advertisement

SpringerLink
Log in

Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons

  • Pros and Cons in Endocrine Practice
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Continuous glucose monitoring associated with intensive insulin regimens represents a useful tool to lower HbA1c in selected adults with type 1 diabetes. Recent randomized controlled trials demonstrated greater glycemic benefits in type 1 diabetic patients treated with multiple daily injections of insulin and continuous glucose monitoring over usual care. These positive outcomes, however, are counter-balanced by several limitations that restrict the use of continuous glucose monitoring in the real life, including the apparent lack of benefits in children and pregnant diabetic women, the high cost, the stringent patients’ selection, and the presence of a multi-disciplinary team with specific expertise. Pros and Cons of using continuous glucose monitoring in type 1 diabetic patients with multiple daily injections of insulin are here discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Diabetes Association.: 6. Glycemic Targets Diabetes Care. 40(Suppl.1), S48–S56 (2017)

  2. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993)

    Article  Google Scholar 

  3. N. Mauras, L. Fox, K. Englert, R.W. Beck, Continuous glucose monitoring in type 1 diabetes. Endocrine 43, 41–50 (2013)

    Article  CAS  PubMed  Google Scholar 

  4. A.L. Peters, A.J. Ahmann, T. Battelino, A. Evert, I.B. Hirsch, M.H. Murad, W.E. Winter, H. Wolpert, Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 3922–3937 (2016)

    Article  CAS  PubMed  Google Scholar 

  5. W.V. Tamborlane, R.W. Beck, B.W. Bode, B. Buckingham, H.P. Chase, R. Clemons, R. Fiallo-Scharer, L.A. Fox, L.K. Gilliam, I.B. Hirsch, E.S. Huang, C. Kollman, A.J. Kowalski, L. Laffel, J.M. Lawrence, J. Lee, N. Mauras, M. O’Grady, K.J. Ruedy, M. Tansey, E. Tsalikian, S. Weinzime, D.M. Wilson, H. Wolpert, T. Wysocki, D. Xing; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Continuous glucose monitoring and intensive treatment of type 1 diabetes. N. Engl. J. Med. 359, 1464–1476 (2008)

    Article  PubMed  Google Scholar 

  6. T. Battelino, I. Conget, B. Olsen, I. Schütz-Fuhrmann, E. Hommel, R. Hoogma, U. Schierloh, N. Sulli, J. Bolinder; SWITCH Study Group, The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55, 3155–3162 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. R.M. Bergenstal, W.V. Tamborlane, A. Ahmann, J.B. Buse, G. Dailey, S.N. Davis, C. Joyce, T. Peoples, B.A. Perkins, J.B. Welsh, S.M. Willi, M.A. Wood; STAR 3 Study Group, Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N. Engl. J. Med. 363, 311–320 (2010)

    Article  CAS  PubMed  Google Scholar 

  8. M.I. Maiorino, G. Bellastella, M. Petrizzo, M.R. Improta, C. Brancario, F. Castaldo, L. Olita, D. Giugliano, K. Esposito, Treatment satisfaction and glycemic control in young type 1 diabetic patients in transition from pediatric health care: CSII versus MDI. Endocrine 46, 256–262 (2014)

    Article  CAS  PubMed  Google Scholar 

  9. M.I. Maiorino, O. Casciano, E. Della Volpe, G. Bellastella, D. Giugliano, K. Esposito, Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study. Endocrine 52, 244–252 (2016)

    Article  CAS  PubMed  Google Scholar 

  10. N.C. Foster, K.M. Miller, W.V. Tamborlane, R.M. Bergenstal, R.W. Beck; T1D Exchange Clinic Network, Continuous glucose monitoring in patients with type 1 diabetes using insulin injections. Diabetes Care 39, e81–e82 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. R.W. Beck, T. Riddlesworth, K. Ruedy, A. Ahmann, R. Bergenstal, S. Haller, C. Kollman, D. Kruger, J.B. McGill, W. Polonsky, E. Toschi, H. Wolpert, D. Price; DIAMOND Study Group, Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317, 371–378 (2017)

    Article  CAS  PubMed  Google Scholar 

  12. M. Lind, W. Polonsky, I.B. Hirsch, T. Heise, J. Bolinder, S. Dahlqvist, E. Schwarz, A.F. Ólafsdóttir, A. Frid, H. Wedel, E. Ahlén, T. Nyström, J. Hellman, Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317, 379–387 (2017)

    Article  CAS  PubMed  Google Scholar 

  13. C.A. van Beers, J.H. DeVries, S.J. Kleijer, M.M. Smits, P.H. Geelhoed-Duijvestijn, M.H. Kramer, M. Diamant, F.J. Snoek, E.H. Serné, Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 4, 893–902 (2016)

    Article  PubMed  Google Scholar 

  14. K.M. Miller, N.C. Foster, R.W. Beck, R.M. Bergenstal, S.N. DuBose, L.A. DiMeglio, D.M. Maahs, W.V. Tamborlane; T1D Exchange Clinic Network, Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care 38, 971–978 (2015)

    Article  PubMed  Google Scholar 

  15. N. Mauras, R. Beck, D. Xing, B. Buckingham, M. Tansey, N.H. White, S.A. Weinzimer, W. Tamborlane, C. Kollman; Diabetes Research in Children Network (DirecNet) Study Group, A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to\10 years. Diabetes Care 35, 204–210 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. M. Tansey, S. Weinzimer, R. Beck, K. Ruedy, P. Cheng, W. Tamborlane, C. Kollman, N. Mauras, L. Fox, J. Coffey, N.H. White; Diabetes Research in Children Network (DirecNet) Study Group, Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to<10 years. Diabetes Care 36, e63 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  17. A.L. Secher, L. Ringholm, H.U. Andersen, P. Damm, E.R. Mathiesen, The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care 36, 1877–1883 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. J.C. Pickup, S.C. Freeman, A.J. Sutton, Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 7(343), d3805 (2011)

    Article  Google Scholar 

  19. U.S. Food and Drug Administration. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm534056.htm, Accessed 16 Mar 2017

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department Medical, Surgical, Neurological, Metabolic Science and Aging, University of Campania “Luigi Vanvitelli”, Naples, Italy

      Maria Ida Maiorino, Giuseppe Bellastella & Katherine Esposito

    2. Diabetes Unit, University of Campania “Luigi Vanvitelli”, Naples, Italy

      Michela Petrizzo & Katherine Esposito

    Authors
    1. Maria Ida Maiorino
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Michela Petrizzo
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Giuseppe Bellastella
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Katherine Esposito
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Maria Ida Maiorino.

    Ethics declarations

    Conflict of interest

    The authors declare that they have no competing interests.

    Ethical approval

    This article does not contain any studies with human participants performed by any of the authors.

    Additional information

    Maria Ida Maiorino and Michela Petrizzo contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Maiorino, M., Petrizzo, M., Bellastella, G. et al. Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons. Endocrine 59, 62–65 (2018). https://doi.org/10.1007/s12020-017-1328-z

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12020-017-1328-z

    Keywords

    Search

    Navigation